Literature DB >> 9059888

Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors.

M Colonna1.   

Abstract

Human NK cells express clonally distributed receptors specific for HLA-A, -B and -C molecules. These receptors belong to the immunoglobulin superfamily and can be functionally distinguished as inhibitory or stimulatory. Inhibitory receptors block NK-cell-mediated cytotoxicity upon binding to HLA class I ligands. This function is mediated by phosphorylation of cytoplasmic tyrosines, which recruit the protein tyrosine phosphatase SHP-1. Stimulatory receptors also bind HLA class I, lack cytoplasmic tyrosine-based motifs, and trigger NK cytotoxicity and proliferation. Both types of receptor are characterized by a limited diversity allowing for recognition of distinct class I supertypic epitopes. This limited diversity is counterbalanced by the expression of different combinations of inhibitory and stimulatory receptors with self and/or non-self HLA class I specificities on distinct NK cell clones. This peculiar strategy allows NK cells to detect loss of MHC class I molecules on autologous transformed and virally infected cells with maximal sensitivity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059888     DOI: 10.1111/j.1600-065x.1997.tb00945.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  24 in total

Review 1.  TAP deficiency syndrome.

Authors:  S D Gadola; H T Moins-Teisserenc; J Trowsdale; W L Gross; V Cerundolo
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  The mother-child union: the case of missing-self and protection of the fetus.

Authors:  W M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 3.  Immunogenetics as a tool in anthropological studies.

Authors:  Alicia Sanchez-Mazas; Marcelo Fernandez-Viña; Derek Middleton; Jill A Hollenbach; Stéphane Buhler; Da Di; Raja Rajalingam; Jean-Michel Dugoujon; Steven J Mack; Erik Thorsby
Journal:  Immunology       Date:  2011-04-11       Impact factor: 7.397

4.  Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy.

Authors:  Kei Ishibashi; Takumi Kumai; Takayuki Ohkuri; Akemi Kosaka; Toshihiro Nagato; Yui Hirata; Kenzo Ohara; Kensuke Oikawa; Naoko Aoki; Naoko Akiyama; Masatoshi Sado; Masahiro Kitada; Yasuaki Harabuchi; Esteban Celis; Hiroya Kobayashi
Journal:  Oncoimmunology       Date:  2016-03-30       Impact factor: 8.110

Review 5.  Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias.

Authors:  A Moretta; D Pende; F Locatelli; L Moretta
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

6.  Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry.

Authors:  Amir Horowitz; Dara M Strauss-Albee; Michael Leipold; Jessica Kubo; Neda Nemat-Gorgani; Ozge C Dogan; Cornelia L Dekker; Sally Mackey; Holden Maecker; Gary E Swan; Mark M Davis; Paul J Norman; Lisbeth A Guethlein; Manisha Desai; Peter Parham; Catherine A Blish
Journal:  Sci Transl Med       Date:  2013-10-23       Impact factor: 17.956

Review 7.  Natural killer cell immune responses.

Authors:  Wayne M Yokoyama
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

8.  The chicken SLAM family.

Authors:  Christian Straub; Birgit C Viertlboeck; Thomas W Göbel
Journal:  Immunogenetics       Date:  2012-10-13       Impact factor: 2.846

9.  TAP deficiency syndrome: chronic rhinosinusitis and conductive hearing loss.

Authors:  Marco Caversaccio; Harald Marcel Bonél; Rachel Carter; Anthony P Williams; Stephan D Gadola
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-19       Impact factor: 2.503

10.  Double-stranded RNA analog and type I interferon regulate expression of Trem paired receptors in murine myeloid cells.

Authors:  Jun Kasamatsu; Mengyao Deng; Masahiro Azuma; Kenji Funami; Hiroaki Shime; Hiroyuki Oshiumi; Misako Matsumoto; Masanori Kasahara; Tsukasa Seya
Journal:  BMC Immunol       Date:  2016-05-03       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.